Yale University

Entecavir safety and effectiveness in a national cohort of treatment-naïve chronic hepatitis B patients in the US - the ENUMERATE study.

TitleEntecavir safety and effectiveness in a national cohort of treatment-naïve chronic hepatitis B patients in the US - the ENUMERATE study.
Publication TypeJournal Article
Year of Publication2015
AuthorsAhn, J., H. M. Lee, J. K. Lim, C. Q. Pan, M. H. Nguyen, W. Ray Kim, A. Mannalithara, H. Trinh, D. Chu, T. Tran, A. Min, S. Do, H. Te, K. R. Reddy, and A. S. Lok
JournalAlimentary pharmacology & therapeutics
Date Published2015 Oct 28
ISSN1365-2036
AbstractEntecavir (ETV) has been shown to be safe and efficacious in randomised controlled trials in highly selected patients with hepatitis B virus (HBV) infection.
DOI10.1111/apt.13440
Alternate JournalAliment. Pharmacol. Ther.

External Links